Cited by 577Virus-based gene therapy researchBiomedical Ethics and RegulationEthics in Clinical Research

The DOI matches its Crossref record.

Virus treatment questioned after gene therapy death

Lehrman, Sally·1999·Nature

DOI 10.1038/43977

Open this paper in CoChat — free account

Integrity signals

Registry

Crossref · 10.1038/43977

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Sorted by citations

Items 501–577 of 577

Myocardial-specific gene delivery
Franz, W.-M., Müller, O. J., Katus, H. A., et al. (2000) · Steinkopff eBooks · doi:10.1007/978-3-642-57710-9_11 · Cited by 1
Biomaterials for Therapeutic Gene Delivery
James, E. N., Ulery, B. D., & Nair, L. S. (2012) · Ceramic transactions /Ceramic transactions · doi:10.1002/9781118511466.ch20 · Cited by 1
Regulatory Aspects in Gene Therapy
Cohen‐Haguenauer, O. (2002) · Springer eBooks · doi:10.1007/978-1-4615-1353-7_14 · Cited by 1
Stellenwert der Gentherapie in der kardiovaskulären Medizin
Auer, J., Berent, R., Schleicher, K., et al. (2000) · Herz · doi:10.1007/pl00001977 · Cited by 1
“Im Zusammenhang mit Adenovirusvektoren können schwere Nebenwirkungen und sogar Todesfälle auftreten [23].”
Background
Gene Editing and Gene Therapy: Entering Uncharted Territory in Veterinary OncologyPreprint
Wierson, W. A., Abel, A. M., Siegler, E. L., Ekker, S. C., Johannes, C. M., Kenderian, S. S., & Mochel, J. P. (2021) · Preprints.org · doi:10.20944/preprints202105.0376.v1
“…perspective, viral vectors can be highly immunogenic and lead to adverse inflammatory reactions in patients such that, in 1999, the first gene therapyrelated fatality was reported in a clinical trial due to an inflammatory reaction in response to an adenovirus (AdV) vector (Lehrman, 1999).”
Background
Steps in a Translational Cancer Gene Therapy Trial
von Holzen, U. W., & Swisher, S. G. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-222-9_25 · Cited by 1
Rationally Designed Synthetic Vectors for Gene Delivery
Rao, G., Yadava, P., & Hughes, J. (2007) · The Open Drug Delivery Journal · doi:10.2174/187412660701017066 · Cited by 1
Molecular therapeutics in hematology: gene therapy
McKillop, W. M., & Medin, J. A. (2024) · doi:10.1002/9781394180486.ch22 · Cited by 1
Single versus repeated intravenous oncolytic reovirus infusions: Implications for immune modulation and rationalised scheduling of therapy in hepatocellular carcinomaPreprint
Scott, K. J., West, E. J., Brownlie, R. J., et al. (2024) · medRxiv · doi:10.1101/2024.09.26.24314049 · Cited by 1
New Technologies in Cardiovascular Research: Gene Therapy
Hedman, M., Turunen, M. P., & Ylä‐Herttuala, S. (2006) · Springer eBooks · doi:10.1007/0-387-23329-6_5 · Cited by 1
Vascular Endothelial Growth Factors and the Bmx Tyrosine Kinase in the Regulation of Angiogenesis and Lymphangiogenesis
Paavonen, K. (2003) · Työväentutkimus Vuosikirja · Cited by 1
Cellular receptors for species B adenoviruses
Marttila, M. (2007) · KTH Publication Database DiVA (KTH Royal Institute of Technology)
Myocardial angiogenesis induced by plasmid VEGF-A165 gene transfer : Experimental and clinical studies
Sarkar, N. (2004) · Figshare
Novel Alternatives to Chemotherapy in Advanced Disease: Gene Transfer
Ghaneh, P., Halloran, C. M., Costello, E., & Neoptolemos, J. P. (2004) · Springer eBooks · doi:10.1007/978-1-85233-904-3_9
Gene Therapy Targets and the Role of Pharmacogenomics in Heart Failure
Lykouras, D., Flordellis, C. S., & Dougenis, D. (2011) · InTech eBooks · doi:10.5772/20004
Self-assembled pentablock copolymers for selective and sustained gene delivery
Zhang, B., & USDOE Office of Science (SC) (2011) · OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) · doi:10.2172/1029551
Emerging Therapies for Heart Failure
Greenberg, B., & Cleland, J. G. F. (2010) · Wiley eBooks · doi:10.1002/9780470669402.ch7
Molecular Genetics of Choroideremia
Freund, P. R., & MacDonald, I. M. (2012) · Encyclopedia of Life Sciences · doi:10.1002/9780470015902.a0024310
Interação do adenovírus humano, sorotipo 41, com células origem hematopoiética: análise da permissividade celular e da expressão gênica viral.
Silva, M. L. (2008) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.42.2008.tde-03062008-190643
Gene Therapy: Cure or Poison? The Proper Role of the FDA in the Bubble Boy Disease Question
Woodruff, M. R. (2004) · Digital Access to Scholarship at Harvard (DASH) (Harvard University)
A non-invasive QPCR method monitoring DNA based therapy of bladder cancer patients
Ayesh, S. K., Abu-lail, R., & HOCHBERG, A. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.02.015
Special Feature Opinion Paper on the Current Status of the Regulation of Gene Therapy in Europe
Cohen‐Haguenauer, O., Rosenthal, F. M., Nsbacher, B. G., et al. (2002)
Therapeutic Innovations in Oncology
Jenkins, C., & Demetri, G. D. (2016) · doi:10.14524/cr-15-0043
Treating Hemophilia by Gene Therapy
Porada, C. D., Ignacio, G., Atala, A., & Almeida-Porada, G. D. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800548-4.00012-7
Ultrasound-based and Non-viral Technologies in Gene Therapy
Su, C., Yeh, H., Hou, C. J., Cheu, Y.-S., & Tsai, C. (2007) · 內科學誌 · doi:10.6314/jimt.2007.18(4).01
Evaluation of the anti-tumour potency and biodistribution of vaccinia virus mutants in solid tumour models
Hughes, J. (2013)
Bioluminescence Imaging of Luciferase Transgenes in Tumor Metastases Models
München, L.-M.-U., & Pharmazeutische, L. F. (2011)
Kardiovaskuläre Gentherapie - was kann der Chirurg derzeit davon erwarten?
Bonatti, J. O., Bernecker, O. Y., Chevtchik, O., Hammerer‐Lercher, A., Laufer, G., Oberhuber, A., Ott, H., Podesser, B. K., Ruttmann, E., Schachner, T., et al. (2002) · Journal für Kardiologie (Krause & Pachernegg GmbH)
Engineering delivery and release of protein therapeutics for mammalian systems
Fluri, D. A. (2008) · Repository for Publications and Research Data (ETH Zurich) · doi:10.3929/ethz-a-005708602
Abnormalities of Hepatic Protein Metabolism
A‐Kader, H. H., & Ghishan, F. K. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4377-0774-8.10072-7
Basic Electrophysiological Procedures for the Clinician
Park, D. S., & Fishman, G. I. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-0285-9.00001-6
Non-viral gene delivery and bone marrow cells in inner ear repair
Tan, B. T. G. (2008) · doi:10.32657/10356/14957
Stand der Gentherapie und der lokalen Medikamentenapplikation im kardiovaskulären Bereich
Nikol, S., & Engelmann, M. G. (2002) · Springer eBooks · doi:10.1007/978-3-642-56302-7_5
Multifunctional nanomaterials for cancer theranostics applications
Anderson, T. (2017) · DR-NTU (Nanyang Technological University) · doi:10.32657/10356/72721
Vers une thérapie génique ex vivo de la dystrophie musculaire de Duchenne : approches lentivirale et intégrase PhiC31
Quenneville, S. (2007) · Corpus Université Laval (Université Laval)
Thérapie génique de la dystrophie musculaire de duchenne : utilisation de transgènes de la dystrophine chez le modèle canin
Pichavant, C. (2010)
Nanosystems for Gene Editing and Targeted Therapy
Lao, Y. (2019) · doi:10.7916/d8-mgjc-9m71
Design of polymeric vectors for genetic manipulation
Lai, W. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816485-3.00004-0
Early Development of the Icon Molecule for Gene Therapy of Cancer and Macular Degeneration
Garen, A. (2019) · American Journal of Biomedical Science & Research · doi:10.34297/ajbsr.2019.06.000992
Gene therapy of malignant glioma : alternative strategies and combination therapies
Stedt, H. (2015) · UEF eRepo (University of Eastern Finland)
Development of enzyme replacement therapy using liver organoids derived from human iPS cells
Ueno, Y., & Taniguchi, H. (2020) · Drug Delivery System · doi:10.2745/dds.35.278
Self-assembled micellar aggregates based monomethoxyl poly(ethylene glycol)-b-poly(e-caprolactone)-b-poly(aminoethyl methacrylate) triblock copolymers as efficient gene delivery vectors
MaFeng, M.-M., Liu, L.-H., YuanFu-jie, Z.-F., et al. (2010)
Genetically modified human umbilical cord blood mononuclear cells as potential stimulators of neuroregeneration in degenerative disorders of central nervous system
Guseva, D. S., Rizvanov, A. A., Kiyasov, A. P., & Islamov, R. R. (2013) · Genes and Cells · doi:10.23868/gc120608
Engineering pseudovirions for large-scale targeted gene transfer and recombinant adeno-associated virus production
Asavarut, P. (2018) · Spiral (Imperial College London) · doi:10.25560/86379
History of Gene Therapy
Bauer, G., & Anderson, J. S. (2014) · SpringerBriefs in biochemistry and molecular biology · doi:10.1007/978-1-4939-0434-1_2
Adventitial ex vivo gene transfer with autologous vascular smooth muscle cells: a superior approach for delivery of therapeutics into the arterial wall?
Min, W. (2004) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2003.12.003
Gene Therapy for Vein Graft Disease
Cable, D. G., & Schaff, H. V. (2006) · Springer eBooks · doi:10.1007/3-540-30084-8_41
Gene Therapy
Lundstrom, K. H. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-818731-9.00137-3
Historical Perspective
(2011) · doi:10.1002/9780470939918.ch1
References
Solter, D., Beyleveld, D., Friele, M. B., Hołówka, J., Lilie, H., Lovell-Badge, R. H., Mandla, C., Martin, U., & Avellaneda, R. P. (2003) · Springer eBooks · doi:10.1007/978-3-662-05117-7_12
Abnormalities of Hepatic Protein Metabolism
A‐Kader, H. H., & Ghishan, F. K. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-67293-1.00072-4
Novel Polymer Systems for Gene Therapy
Diaz‐Dussan, D., Peng, Y., & Narain, R. (2022) · doi:10.1002/9783527815562.mme0020
Gene Therapy
Choi, V. W., & Samulski, R. J. (2009) · Springer eBooks · doi:10.1007/978-3-540-37654-5_40
一种线性化聚乙烯亚胺介导的EGFR靶向siRNA转运系统在人肺腺癌细胞中的优化与评价研究
张萍海, 周磊, 徐欣, et al. (2009) · Science in China Series C-Life Sciences (in Chinese) · doi:10.1360/zc2009-39-12-1128
Strategies and applications of cell surface engineering
Huang, Y., & Wang, B. (2022) · Scientia Sinica Vitae · doi:10.1360/ssv-2022-0067
Nanomaterials Mediated Diagnosis of Lung Cancer
Kotha, A. K., Kashikar, R., Famta, P., Shah, S., Srivastava, S., & Chougule, M. B. (2022) · Springer eBooks · doi:10.1007/978-3-031-09636-5_8
Adenovirus vectors for vaccination and cancer gene therapy
Boussettine, R., Hassou, N., Bessi, H., et al. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-85496-2.00029-4
Points to consider for non-clinical safety evaluation of in vivo gene therapy products
Naota, M., & Maki, K. (2023) · Translational and Regulatory Sciences · doi:10.33611/trs.2023-002
Delivery of Rna Drugs: Beyond the Liver, More than VaccinePreprint
Elnaggar, M. G., He, Y., & Yeo, Y. (2023) · SSRN Electronic Journal · doi:10.2139/ssrn.4657914
Genetic diagnosis and gene therapy approaches: Current status and limitations
Singh, P., Sharma, S., Haque, F. U., et al. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-22264-1.00002-5
Gene Therapy
Orchard, P. J., & McIvor, R. S. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-383-5_14
Abnormalities of Hepatic Protein Metabolism
Elfar, W., & Ghishan, F. K. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-11760-2.00073-2
Genetics and genomics
Chatfield, K. C., Lee, T. M., & Nees, S. N. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-13279-7.00042-0
Synthesis and DNA binding studies of pyrene-functionalized cationic block copolymer based on D-galactopyranose and 2-(dimethylamino)ethyl methacrylate
Yıldız, U., ALTINOK, İ., Arslan, H., & Çoban, B. (2025) · Journal of Chemical Sciences · doi:10.1007/s12039-025-02436-0
“1,2 For these reasons, non-viral deliveries are attractive alternatives to viral systems for DNA delivery.”
Cell therapy limits loss of vision in an animal model of retinal degenerative disease
McGill, T. J. (2004) · Open ULeth Scholarship (OPUS) (University of Lethbridge)
ナノバイオテクノロジーが先導する診断・治療イノベーション―超分子ナノデバイスによる薬物・遺伝子のピンポイントデリバリー―
有, 松., & Kataoka, K. (2010) · 耳鼻咽喉科展望 · doi:10.11453/orltokyo.53.360
Lipoplexes recouverts d’acide hyaluronique pour le ciblage d’ARN interférant à des cellules tumorales surexprimant le récepteur CD44
Nascimento, T. L. (2015) · doi:10.70675/382bdfa3z26a9z46aazb229zaee7e2c6b2c4
Gene therapy approach on Charcot-Marie-Tooth type 1A rats
Hajjar, H. (2018) · theses.fr (ABES) · doi:10.70675/014f2329za7dbz40a5z9c75z92e60af2b4a0
PEGylated cationic polyacrylates for transfection : synthesis, characterization, DNA complexation and cytotoxicity
Bohec, M. L. (2017) · theses.fr (ABES) · doi:10.70675/a68d89d5zc8aaz4c5ez9b30ze6b3c22f7fa2
A yellow fever 17D and Usutu virus chimera with rationally designed mutations in the envelope protein is lethal in an Ifnar-/- mouse model
Duyvestyn, J. M., Bredenbeek, P. J., Thaler, M., et al. (2026) · Virology Journal · doi:10.1186/s12985-026-03145-x
“Use of extremely high doses of non-replicating particles caused lethality in a human trial with recombinant adenovirus vector vaccine [13, 38], raising the possibility that increased numbers of non-infectious rUSUV-FVR particles (compared to WT) caused immunopathology and faster death [39].”
Advances in Polyethyleneimine‐Derived Nanoformulations
Attia, M. S., Skwarczyński, M., & Hussein, W. M. (2026) · Small Science · doi:10.1002/smsc.70330 · Cited by 1
“Viral vectors can efficiently deliver genes but are limited by toxicity, immunogenicity, and risk of mutations, prompting research into nonviral delivery systems as safer options [4, 11].”
Base Editing: Mechanisms and Therapeutic Applications
Catalano, F. (2026) · Methods in molecular biology · doi:10.1007/978-1-0716-5547-4_4 · Cited by 1
Noninvasive Delivery of DNA Into the Eye
Nickerson, J. M., Shuler, R. K., Davies, J. B., Dioguardi, P. K., Wolchok, S. M., Ciavatta, V. T., Boatright, J. H., & Edelhauser, H. F. (2006) · Humana Press eBooks · doi:10.1007/978-1-59745-047-8_21
Topoisomerase-II mediated biochemical mapping of centromeres and nitroreductase mediated drug metabolism in Trypanosomatids
Bot, C. (2012) · OpenGrey (Institut de l'Information Scientifique et Technique)
Promoter-targeted anti-nociceptive HSV-1 vectors have differential effects on pain based on the neuronal population targeted
Doyal, M. F. (2015) · D-Scholarship@Pitt (University of Pittsburgh)
RNA Interference and MicroRNA Modulation for the Treatment of Cardiac Disorders
Poller, W. C., Suckau, L., Pinkert, S., & Fechner, H. (2008) · Springer eBooks · doi:10.1007/978-3-540-78709-9_8
“That tragic event prompted thorough additional investigations (Lehrman 1999; Marshall 2000) into the risks of adenovector-mediated gene therapy including serious adverse events even if they may occur only very rarely, in predisposed individuals, or at very high vector doses.”
Background
Immune Reaction Following Cell and Gene Therapy
Tremblay, J. P. (2000) · Birkhäuser Boston eBooks · doi:10.1007/978-1-4612-2126-5_13

Authors: Lehrman, S.
Corresponding author: Lehrman, Sally
ORCID: Lehrman, Sally
Venue: Nature
Publisher: Springer Science and Business Media LLC
Published: 1999-10-07
Volume: 401
Issue: 6753
Pages: 517-518
ISSN: 0028-0836 (ISSN-L)
1476-4687
DOI: 10.1038/43977
OpenAlex: W1606853210
Cited by: 576
References: 0
Citations by year: 2026: 6 · 2025: 9 · 2024: 11 · 2023: 15 · 2022: 17 · 2021: 12 · 2020: 18 · 2019: 16 · 2018: 18 · 2017: 14 · 2016: 14 · 2015: 24 · 2014: 30 · 2013: 23 · 2012: 31
Type: other
Language: en
Open access: closed
Licence: www.springernature.com/gp/researchers/text-and-data-mining (tdm)
www.springernature.com/gp/researchers/text-and-data-mining (vor)
Locations: Nature (publishedVersion)
PubMed (publishedVersion)
RePEc: Research Papers in Economics (submittedVersion)
DigitalGeorgetown (Georgetown University Library) (submittedVersion)
Funders: Brigham and Women's Hospital
University of East Anglia
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
Health Sciences › Nursing › Issues, ethics and legal aspects › Biomedical Ethics and Regulation
Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Ethics in Clinical Research
Keywords: gene therapy, viral vectors, recombinant adeno-associated virus, clinical trial safety
MeSH terms: Adenoviridae, Adult, Fever, Genetic Vectors, Humans, Male, Ornithine Carbamoyltransferase, Thrombosis, Genetic Therapy, Clinical Trials, Phase I as Topic, Fatal Outcome, Risk Assessment, Ornithine Carbamoyltransferase Deficiency Disease, Advisory Committees, Government Regulation, Federal Government, Research Subjects

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Virus treatment questioned after gene therapy death

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cited by

Related

Metadata

Record

About these checks